Operations

Compugen Announces $21 Million Registered Direct Offering of Ordinary Shares and Warrants

June 15, 2018

HOLON, Israel, June 15, 2018 /PRNewswire/ — Compugen Ltd. (Nasdaq: CGEN)(CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors providing for the issuance of approximately 5.3 million of its ordinary shares at a purchase price […]

Retrophin Announces Expansion of Intellectual Property Estate for Sparsentan with Newly Issued U.S. Patent

June 14, 2018

SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent covering the Company’s product candidate sparsentan which, in addition to being in Phase 3 clinical development for the treatment of focal segmental glomerulosclerosis (FSGS), is advancing to Phase […]

Azar backs protections for preexisting conditions, skirting administration’s legal stance

June 14, 2018

Health and Human Services Secretary Alex Azar told lawmakers Tuesday that he wants to preserve access to affordable insurance for Americans with preexisting medical conditions, but he declined to disclose his view of an administration move that could undercut such consumer protections. Calling it “a constitutional position . . . not a policy position,” Azar sidestepped grilling […]

Achema 2018: Lifetime Efficiency – new comprehensive concept exploits untapped potentials for users in the production of solid formulations

June 14, 2018

Fette Compacting has developed a new service offering for the optimization of tablet production and capsule filling under the name Lifetime Efficiency. This service is based on the comprehensive analysis and systematic improvement of all production processes. It enables users not only to exploit previously untapped potentials, but also to increase the efficiency of production […]

Sharp Packaging: Leading contract packager selects Werum IT Solutions as strategic MES partner

June 14, 2018

Sharp Packaging: Leading contract packager selects Werum IT Solutions as strategic MES partner Manufacturing Execution System (MES) as differentiator to digitize operations and improve business opportunities / PAS-X compatibility and a shared customer base key decisive factors / First implementation in Dutch packaging facility Lüneburg, Germany, 14 June 2018 – Following a global bidding process, […]

Sanofi and Recipharm announce transfer of Holmes Chapel Manufacturing site

June 14, 2018

Recipharm and Sanofi announced today that they have signed an agreement to transfer the Holmes Chapel site from global healthcare leader, Sanofi, to leading pharmaceutical contract development and manufacturing organisation, Recipharm. “Holmes Chapel brings Recipharm an ideal opportunity to accelerate its offering to customers with access to novel respiratory products. As an already successful CMO […]

IQVIA Announces Launch of Secondary Public Offering and Repurchase of Common Stock

June 13, 2018

DANBURY, Conn., & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) announced today the launch of an underwritten, secondary public offering of 12,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc., investment funds associated with Bain Capital Investors, […]

Synergy Pharmaceuticals Announces Amendment to CRG Debt Agreement

June 13, 2018

NEW YORK–(BUSINESS WIRE)–Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that it has received a waiver to extend the draw down date of the second borrowing under its Term Loan Agreement with CRG LP from June 30, 2018 to August 29, 2018. […]

MeiraGTx Announces Closing of Initial Public Offering

June 13, 2018

LONDON and NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the closing of its initial public offering of 5,000,000 ordinary shares at a public offering price of $15.00 per share. The gross proceeds to MeiraGTx, before underwriting discounts and commissions, are […]

Sanofi : Sanofi successfully prices USD 2 billion bond issue

June 13, 2018

Paris, France – June 13, 2018 – Sanofi has successfully priced its offering of USD 2 billion of notes denominated in US dollars, across 2 tranches:     USD 1 billion fixed rate notes, due June 19, 2023, bearing interest at an annual rate of 3.375%, USD 1 billion fixed rate notes, due June 19, […]

TiGenix announces a change in its Board of Directors and its Management Team

June 13, 2018

Leuven (Belgium) – June 13, 2018, 07:00h CEST – TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for serious medical conditions, today announces that Eduardo Bravo will depart the board of directors and his role as […]

InSphero Receives Additional USD 10m for Organ-on-a-Chip Disease Models

June 13, 2018

Schlieren, Switzerland, June 13, 2018 (GLOBE NEWSWIRE) — InSphero AG today announced that it has raised USD 10 million in its latest funding round with additional financing, secured from internal and external investors, bringing its total funding to date to USD 35 million. An innovative provider of 3D cell-based platforms for drug discovery and efficacy […]

Catalyst Pharmaceuticals Appoints Daniel J. Brennan as Chief Commercial Officer

June 13, 2018

CORAL GABLES, Fla., June 13, 2018 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced the appointment of Daniel J. Brennan as Chief Commercial Officer. Mr. Brennan will be responsible for leading the Company’s […]

VistaGen Therapeutics Issued Two Key U.S. Patents for Treatment of Depression with AV-101

June 13, 2018

SOUTH SAN FRANCISCO, Calif., June 13, 2018 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (NASDAQ:VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central nervous system (CNS) diseases and disorders, today announced that the U.S. Patent and Trademark Office (USPTO) has issued the following two key U.S. patents related to AV-101, VistaGen’s […]

Sarepta Therapeutics Enters into Long-term Strategic Manufacturing Partnership with Brammer Bio to Support Gene Therapy Development and Commercial Supply

June 13, 2018

CAMBRIDGE, Mass., June 13, 2018 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, announced today that it has entered into a long-term strategic manufacturing partnership with Brammer Bio, which will provide Sarepta access to clinical and commercial […]

BioXcel Therapeutics Appoints Dr. Cedric Burg as Vice President and Head of Global Clinical Operations and Project Management

June 13, 2018

BRANFORD, Conn., June 13, 2018 — BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq: BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines across neuroscience and immuno-oncology, today announced the appointment of Dr. Cedric Burg as Vice President and Head of Global Clinical Operations and Project Management. Dr. Burg […]

Four 3D Leadership Group Coaches to Participate in Women’s Coaching Circle Event with WEST – Women in the Enterprise of Science and Technology

June 13, 2018

BOSTON, MA, ISSUED JUNE 12, 2018…Four executive coaches from 3D Leadership Group (http://3dleadershipgroup.com), a Boston-based leadership development firm, have been selected to participate in a women’s coaching circle event for WEST – Women in the Enterprise of Science and Technology. The event is scheduled to take place on Wednesday, June 20, at the Broad Institute […]

Lihua Yu, Ph.D., Appointed President & Chief Data Sciences Officer, H3 Biomedicine

June 12, 2018

WOODCLIFF LAKE, N.J., June 11, 2018 /PRNewswire/ — Eisai Inc. announced today the appointment of Lihua Yu, Ph.D., to President & Chief Data Sciences Officer, H3 Biomedicine, the cancer genomics based drug discovery company of Eisai. In her new role, Dr. Yu will be responsible for the overall scientific and business direction of H3. Dr. […]

Endo Announces Master Settlement Agreement Allowing for Resolution of Known Testosterone Replacement Therapy Product Liability Claims and Entry of Significant Case Management Order

June 12, 2018

DUBLIN, June 11, 2018 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries Endo Pharmaceuticals Inc. and Auxilium Pharmaceuticals, LLC (collectively, “Endo” or the “Company”) have executed a definitive master settlement agreement (the “Agreement”) allowing for the resolution of all known testosterone replacement therapy product liability claims against the Company. Under the […]

FEEDBACK